Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose Escalation of Lobaplatin with IMRT for NPC
NCT03188497Phase 1Completed
- Sponsor
- The Fifth Affiliated Hospital of Sun Yat-sen University
- Start
- Jun 2016
- Primary completion
- Dec 2017
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 1, open-label trial of lobaplatin in nasopharyngeal carcinoma (NPC) (6 arms), sponsored by The Fifth Affiliated Hospital of Sun Yat-sen University. Primary endpoints: Platelet count at 1 year, Leukocyte count at 1 year and 2 more. Started Jun 2016; status: completed.
02
Drugs
lobaplatin
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT03188497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03188497.